Arq-e-Ajeeb for COVID-19

 Arq-e-Ajeeb has been reported as potentially beneficial for COVID-19 in the following studies.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed Arq-e-Ajeeb in detail.
Kumar et al., Immunomodulatory effect of Unani polyherbal formulation - Tiryaq Wabai in mild to moderate COVID-19 patients – A randomized placebo-controlled clinical trial, Journal of Ayurveda and Integrative Medicine, doi:10.1016/j.jaim.2024.100903
Kumar et al., Effect of three Unani formulations (Tiryaq wabai, Arq-e-ajeeb, and Habb-e-loban) as an adjuvant to standard care treatment in the management of mild to moderate COVID-19 patients – a placebo-controlled, clinical trial., Journal of Herbal Medicine, doi:10.1016/j.hermed.2023.100788